Friday, July 18, 2025 9:24:11 PM
SkyLimit, All that "free advice" from Shorts makes me think of this.
The Boiling Water Lesson
A father had two daughters and one suitor. He told them: "Whichever daughter's pot of water boils first gets to marry him."
One daughter desperately wanted to get married, so she kept lifting the lid and releasing heat each time. The other daughter, who didn't want to marry, never opened her pot - and her water boiled first. Ironic.
The Investment Truth
Due diligence is like adding heat to a pot of water. It is the science. Be wary of Short's "free advice" to get you angry and start second-guess yourself. Don't lose your DD by opening the lid and turning all that converted energy from liquid to gas into wasted energy.
No matter how much heat one puts on NWBO, the DCVax-L approval is with the regulators. One can't increase the temperature of water above 100 degrees with impatience.
The shorts know this. They're not trying to out-research; they're trying to gift Retail investors "free advice" - a Trojan Horse of anger and impatience. They know even investors with solid DD will sabotage themselves if made restless enough.
For NWBO: The science will determine the outcome, not daily price action, not being anxious. Do your DD. Trust it. Then keep the lid closed and let the energy build.
The Boiling Water Lesson
A father had two daughters and one suitor. He told them: "Whichever daughter's pot of water boils first gets to marry him."
One daughter desperately wanted to get married, so she kept lifting the lid and releasing heat each time. The other daughter, who didn't want to marry, never opened her pot - and her water boiled first. Ironic.
The Investment Truth
Due diligence is like adding heat to a pot of water. It is the science. Be wary of Short's "free advice" to get you angry and start second-guess yourself. Don't lose your DD by opening the lid and turning all that converted energy from liquid to gas into wasted energy.
No matter how much heat one puts on NWBO, the DCVax-L approval is with the regulators. One can't increase the temperature of water above 100 degrees with impatience.
The shorts know this. They're not trying to out-research; they're trying to gift Retail investors "free advice" - a Trojan Horse of anger and impatience. They know even investors with solid DD will sabotage themselves if made restless enough.
For NWBO: The science will determine the outcome, not daily price action, not being anxious. Do your DD. Trust it. Then keep the lid closed and let the energy build.
Bullish
Sharing thoughts and opinions. To participate in group due diligence. Motto: Do not be a gullible FUDdable investor.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
